Many EU HTA Bodies Wary Of Involvement In 'ADAPT SMART' MAPPs Project
This article was originally published in SRA
Efforts are being made to involve more health technology assessment (HTA) bodies in the ADAPT SMART initiative, which is intended to coordinate Medicines Adaptive Pathways to Patients (MAPPs) activities in Europe. However, many HTAs are reluctant to take part, partly because of resource issues and partly because they do not want to invest public funding in projects involving private companies.
You may also be interested in...
Coronavirus Notebook: EU Publishes CureVac Vaccine Contract, AZ and Pfizer Under Attack Over Supply Cuts
The European Ombudsman has opened an inquiry regarding the disclosure of vaccine contracts with other companies, and the European Commission is planning a “sharing mechanism” for vaccines bought by EU member states.
Australia will begin its coronavirus vaccination program with Comirnaty. The Oxford University/AstraZeneca vaccine is expected to be the next to receive approval.
Hungary is going its own way when it comes to coronavirus vaccines, but its decision to allow the emergency use of the Oxford University/AstraZeneca vaccine may be only a symbolic expression of the government’s growing impatience with the EU.